Log in to save to my catalogue

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardio...

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2323447576

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study

About this item

Full title

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-12, Vol.14 (12), p.e0226303-e0226303

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Metformin treatment (1000-2000 mg/day) over 6 months in pubertal children and/or adolescents with obesity and hyperinsulinism is associated with a reduction in body mass index (BMI) and the insulin resistance index (HOMA-IR). We aimed to ascertain if long-term treatment (24 months) with lower doses of metformin (850 mg/day) normalizes the endocrine...

Alternative Titles

Full title

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2323447576

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2323447576

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0226303

How to access this item